Condition

Schizophrenia (3)

Acute Myeloid Leukemia (1)

Anxiety Disorders (1)

Dementia (1)

Depression (1)

Psychosomatic Disorders (1)

Schizoaffective Disorders (1)

Schizophrenia and Disorders With Psychotic Features (1)

Overall Status

Completed (3)

Terminated (1)

Phase

phase 1 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Hannover Medical School (1)

Janssen Scientific Affairs, LLC (1)

Ontario Clinical Oncology Group (OCOG) (1)

Technical University of Munich (1)

Collaborator

Hamilton Health Sciences Corporation (1)

Juravinski Cancer Centre Foundation (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational (1)

thioridazine

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders Trial in Munich (Olanzapine,

Completed

Schizophrenia
+2 more

Olanzapine
+18 more

Munich, Bavaria, Germany

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psycho

Oct 10, 2018

Family Intervention in Recent Onset Schizophrenia Treatment

Completed

Schizophrenia

Caregiver psycho-education and skills training
+22 more

Bullhead City, Arizona
+33 more

Jan 21, 2019

Dementia, Depression, Schizophrenia Trial in Germany (Phenobarbital, Phenytoin, Carbamazepine)

Terminated

Dementia
+4 more

Phenobarbital
+96 more

Augsburg, Germany
+4 more

Feb 27, 2018

Acute Myeloid Leukemia Trial in Hamilton (Thioridazine)

Completed

Acute Myeloid Leukemia

Thioridazine

Hamilton, Ontario, Canada

Juravinski Hospital & Cancer Centre

Dec 6, 2016